The TREND Study: Tapered Reduction in Energy Intake as a Novel Approach to Dieting
TREND
1 other identifier
interventional
22
1 country
1
Brief Summary
TREND is a pilot randomized trial comparing two alternative methods of initiating a low-calorie weight loss diet. The study will compare the traditional diet initiation of abruptly dropping energy intake to 1000 kcal/day for women and 1200 kcal/day for men versus a 6 week tapering of energy intake from a baseline level. These two approaches will be compared with respect to their impact on energy regulatory systems of the body, weight loss and other measures, up to a year after diet initiation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started Aug 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2016
CompletedFirst Posted
Study publicly available on registry
July 19, 2016
CompletedStudy Start
First participant enrolled
August 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 11, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 11, 2018
CompletedAugust 21, 2018
August 1, 2018
1.8 years
July 15, 2016
August 17, 2018
Conditions
Outcome Measures
Primary Outcomes (2)
Ghrelin
Orexogenic hormone
change from baseline at weeks 1, 6, 12, 24, 52
Leptin
Satiety hormone
change from baseline at weeks 1, 6, 12, 24, 52
Secondary Outcomes (6)
Glucagon-like peptide-1 (GLP1)
change from baseline at weeks 1, 6, 12, 24, 52
Body Composition (percent body fat, percent lean mass)
change from baseline at week 24 and 52
Resting Metabolic Rate (RMR)
change from baseline at weeks 12, 24, 52
Weight (kg)
Change from baseline at weeks 6, 12, 24 and 52
Hunger
weeks 1, 6, 12, 24, 52
- +1 more secondary outcomes
Study Arms (2)
Tapered Diet
EXPERIMENTALTraditional Low Calorie Diet
ACTIVE COMPARATORInterventions
All participants will start with a 3 week run-in period during which they are fed a diet at 1.4 x their resting metabolic rate (kcal). Participants who are weight stable at the end of run in and are randomized to the Tapered Diet Arm will undergo the following 24 week feeding study intervention. The difference between a participant's run-in period energy intake and low-calorie "prescribed" energy intake (1000 kcal for women; 1200kcal for men) will be divided by six. At weekly intervals from weeks 1-6, daily caloric intake will be decreased by this fixed amount, reaching the final daily caloric goal (1000 kcals for women and 1200 kcals for men) by the end of the 6th week. Participants will present twice per week during weeks 1-6 to receive food that sums to that week's prescribed calorie level. From weeks 7-24, these participants will then follow a traditional low-calorie diet, still presenting for food pickups twice per week at a stable caloric level during this period.
All participants will start with a 3 week run-in period during which they are fed a diet at 1.4 x their resting metabolic rate (kcal). Participants who are weight stable at the end of run in and are randomized to the Traditional Diet Arm will undergo the following 24 week feeding study intervention. Immediately following run-in, these participants will start a low-calorie diet (1000 kcal per day for women; 1200kcal for men) Participants will present twice per week during weeks 1-24 to receive food that sums to that week's prescribed calorie level.
Eligibility Criteria
You may qualify if:
- Employee of Wake Forest Baptist Medical Center
- BMI 30-40 kg/m2
- Interested in weight loss
- \<90 min/wk of exercise at baseline
- Receives medical care through Wake Forest and has WakeOne account
You may not qualify if:
- Already participating in another diet or weight loss program or research study
- History of bariatric surgery
- History of eating disorder
- History of cancer (other than non-melanomatous skin cancer)
- History of thyroid disease
- History of severe mental illness
- Diagnosis of diabetes
- Currently pregnant, breastfeeding or planning pregnancy
- Peri or post-menopausal
- Food allergies or sensitivities
- Vegetarian
- Night Shift worker
- Planning prolonged travel in next 6-8 months or frequent out of town travel
- on any medication that could promote weight loss or weight gain
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kristina H Lewis, MD MPH SM
Wake Forest University Health Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 15, 2016
First Posted
July 19, 2016
Study Start
August 1, 2016
Primary Completion
May 11, 2018
Study Completion
May 11, 2018
Last Updated
August 21, 2018
Record last verified: 2018-08